PubMed

Pharmacogenetics of efavirenz: adherence and virologic outcomes.

Cennimo DJ.

Ann Intern Med. 2007 Dec 4;147(11):817; author reply 817-8. No abstract available. PMID: 18056676 [PubMed - indexed for MEDLINE]Related articlesFree article

Efavirenz: a review.

Vrouenraets SM, Wit FW, van Tongeren J, Lange JM.

Expert Opin Pharmacother. 2007 Apr;8(6):851-71. Review.PMID: 17425480 [PubMed - indexed for MEDLINE]Related articles

Efavirenz.

Maggiolo F.

Expert Opin Pharmacother. 2007 Jun;8(8):1137-45. Review.PMID: 17516877 [PubMed - indexed for MEDLINE]Related articles

Efavirenz for HIV-1 infection in adults: an overview.

Fortin C, Joly V.

Expert Rev Anti Infect Ther. 2004 Oct;2(5):671-84. Review.PMID: 15482231 [PubMed - indexed for MEDLINE]Related articles

Summaries for patients. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and patient outcomes.

[No authors listed]

Ann Intern Med. 2007 Apr 17;146(8):I28. No abstract available. PMID: 17438312 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication.

Stöhr W, Back D, Dunn D, Sabin C, Winston A, Gilson R, Pillay D, Hill T, Ainsworth J, Pozniak A, Leen C, Bansi L, Fisher M, Orkin C, Anderson J, Johnson M, Easterbrook P, Gibbons S, Khoo S; Liverpool TDM Database; UK CHIC Study.

Antivir Ther. 2008;13(5):675-85.PMID: 18771051 [PubMed - indexed for MEDLINE]Related articles

[The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection]

van Leth F, Lange JM.

Ned Tijdschr Geneeskd. 2006 Aug 5;150(31):1719-22. Review. Dutch. PMID: 16924943 [PubMed - indexed for MEDLINE]Related articles

Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.

Schackman BR, Ribaudo HJ, Krambrink A, Hughes V, Kuritzkes DR, Gulick RM.

J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):547-54.PMID: 18193496 [PubMed - indexed for MEDLINE]Related articles

Virologic outcomes of complex drug regimens for human immunodeficiency virus.

Carr A.

JAMA. 2002 Nov 20;288(19):2405-6; author reply 2406. No abstract available. PMID: 12435249 [PubMed - indexed for MEDLINE]Related articles

Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.

Haas DW, Smeaton LM, Shafer RW, Robbins GK, Morse GD, Labbe L, Wilkinson GR, Clifford DB, D'Aquila RT, De Gruttola V, Pollard RB, Merigan TC, Hirsch MS, George AL Jr, Donahue JP, Kim RB.

J Infect Dis. 2005 Dec 1;192(11):1931-42. Epub 2005 Nov 1.PMID: 16267764 [PubMed - indexed for MEDLINE]Related articles

Clinical impact of patient population differences and genomic variation in efavirenz therapy.

King J, Aberg JA.

AIDS. 2008 Sep 12;22(14):1709-17. Review.PMID: 18753940 [PubMed - indexed for MEDLINE]Related articles

Intracellular efavirenz levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals.

Tanaka R, Hanabusa H, Kinai E, Hasegawa N, Negishi M, Kato S.

Antimicrob Agents Chemother. 2008 Feb;52(2):782-5. Epub 2007 Dec 10.PMID: 18070970 [PubMed - indexed for MEDLINE]Related articlesFree article

Human genetic variability and HIV treatment response.

Haas DW.

Curr HIV/AIDS Rep. 2006 Jul;3(2):53-8. Review.PMID: 16608660 [PubMed - indexed for MEDLINE]Related articles

Efavirenz and nevirapine in HIV-1 infection : is there a role for clinical pharmacokinetic monitoring?

Dahri K, Ensom MH.

Clin Pharmacokinet. 2007;46(2):109-32. Review.PMID: 17253884 [PubMed - indexed for MEDLINE]Related articles

Building a better nucleoside/nucleotide analogue backbone: pharmacokinetic and resistance considerations.

Zolopa AR.

AIDS Read. 2003 Sep:S9-15. Review. No abstract available. PMID: 14601554 [PubMed - indexed for MEDLINE]Related articles

Factors affecting adherence and convenience in antiretroviral therapy.

Lafeuillade A.

Int J STD AIDS. 2001 Nov;12 Suppl 4:18-24. Review. No abstract available. PMID: 11589824 [PubMed - indexed for MEDLINE]Related articles

Resistance and other factors involved in therapy failure.

Mallol S.

Antivir Ther. 2001;6 Suppl 2:21-7. No abstract available. PMID: 11678475 [PubMed - indexed for MEDLINE]Related articles

[Efavirenz--comprehensive status of studies]

[No authors listed]

MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:79-81. German. No abstract available. PMID: 16385886 [PubMed - indexed for MEDLINE]Related articles

Efavirenz-containing highly active antiretroviral therapy in an HIV-infected patient with myasthenia gravis.

Chiesa E, Bongiovanni M, Melzi S, Bini T, d'Arminio Monforte A.

AIDS. 2003 Nov 21;17(17):2544-5. No abstract available. PMID: 14600531 [PubMed - indexed for MEDLINE]Related articles

The role of therapeutic drug monitoring in treatment of HIV infection.

Back DJ, Khoo SH, Gibbons SE, Merry C.

Br J Clin Pharmacol. 2001 Apr;51(4):301-8. Review. No abstract available. PMID: 11318764 [PubMed - indexed for MEDLINE]Related articlesFree article